Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gateways to clinical trials.

M Bayés1, X Rabasseda, J R Prous

  • 1Prous Science, S.A., Barcelona, Spain. mbayes@prous.com

Methods and Findings in Experimental and Clinical Pharmacology
|May 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the American Association of Urology Annual Meeting 2015 (May 15-19 - New Orleans, Louisiana, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 73rd Annual Meeting of the American Academy of Dermatology (March 20-24 - San Francisco, California, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the European Association for the Study of the Liver's 50th International Liver Congress (April 22-26 - Vienna, Austria).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

This guide provides an overview of recent clinical trials across various therapeutic areas, featuring a comprehensive list of investigational drugs and their development status. It serves as a valuable resource for researchers and clinicians tracking novel pharmaceutical advancements.

Area of Science:

  • Pharmaceutical Sciences
  • Clinical Research
  • Drug Development

Context:

  • Gateways to Clinical Trials compiles data from Prous Science Integrity(R) to track emerging drug candidates.
  • This issue highlights a broad spectrum of drugs undergoing clinical investigation, spanning multiple therapeutic areas.
  • The information is sourced from current literature and congresses, reflecting the latest advancements.

Purpose:

  • To provide a comprehensive overview of ongoing clinical trials.
  • To list and categorize a wide range of investigational drugs currently in development.
  • To serve as a reference for the latest clinical trial data and drug candidates.

Summary:

  • Presents a curated list of investigational drugs, including ABI-007, adalimumab, adefovir dipivoxil, alefacept, alemtuzumab, and many others.

Related Experiment Videos

  • Details drugs such as Bevacizumab, bortezomib, bosentan, cetuximab, darbepoetin alfa, and duloxetine hydrochloride in clinical development.
  • Includes updates on Eculizumab, erlotinib hydrochloride, everolimus, gefitinib, imatinib mesylate, and Natalizumab, among others.

    • Impact:

    • Facilitates informed decision-making for researchers and clinicians in drug discovery and development.
    • Enhances discoverability of novel therapeutic agents and ongoing clinical studies.
    • Supports the advancement of pharmaceutical research by consolidating critical trial information.